| 000 | 05095namaa22004451i 4500 | ||
|---|---|---|---|
| 003 | OSt | ||
| 005 | 20250807115326.0 | ||
| 008 | 250623s2024 ua a|||frm||| 000 0 eng d | ||
| 040 | 
_aEG-GICUC _beng _cEG-GICUC _dEG-GICUC _erda  | 
||
| 041 | 0 | 
_aeng _beng _bara  | 
|
| 049 | _aDeposit | ||
| 082 | 0 | 4 | _a636.8 | 
| 092 | 
_a636.8 _221  | 
||
| 097 | _aPh.D | ||
| 099 | _aCai01.10.05.Ph.D.2024.Gh.C | ||
| 100 | 0 | 
_aGhada Mohamed Mohamed Ahmed Khalil, _epreparation.  | 
|
| 245 | 1 | 0 | 
_aClinicopathological studies on some novel renal biomarkers in cats / _cby Ghada Mohamed Mohamed Ahmed Khalil ; Supervised Prof. Dr. Safaa Y. S. Ahmed, Prof. Dr. Shaymaa I. Salem, Prof. Dr. Khaled M. A. Mahran, Dr. Mohamed E. Ali.  | 
| 246 | 1 | 5 | _aدراسات باثولوجية إكلينيكو لبعض دلالات الكلى الحيوية الحديثة في القطط | 
| 264 | 0 | _c2024. | |
| 300 | 
_a98 pages :  _billustrations ; _c25 cm. + _eCD.  | 
||
| 336 | 
_atext _2rda content  | 
||
| 337 | 
_aUnmediated _2rdamedia  | 
||
| 338 | 
_avolume _2rdacarrier  | 
||
| 502 | _aThesis (Ph.D)-Cairo University, 2024. | ||
| 504 | _aBibliography: pages 74-97. | ||
| 520 | 3 | _aRenal diseases are common disorders of felines, considered a leading death cause, and exhibit a diagnostic challenge due to a shortage of early damage markers. The traditional biomarkers [e.g., serum creatinine (sCr) and blood urea nitrogen (BUN)] have low diagnostic sensitivity; thus, acute cases progress to chronic. This study aimed to clarify the clinicopathological, ultrasonographic, and pathological findings of cats affected with renal diseases, and the performance of novel renal biomarkers [symmetric dimethyl arginine (SDMA), kidney injury molecule-1 (KIM-1), Tamm-Horsfall protein (THP), and N-acetyl-β-D-glucosaminidase (NAG)] against the traditional ones. Furthermore, assessing the novel biomarker‟s role in the follow-up of treated cases. 86 cats were allocated into 4 groups depending on clinical signs, physical examination, sCr concentration, and urine specific gravity (USG) as follows: I. Control negative group (15 apparently healthy cats), II. Control positive group (22 renal diseased cats), III. Pre- azotemic group (31 cats), and IV. Diseased and treated group (18 treated cats). Blood and spot urine samples were collected from all groups. Blood samples for hematological, biochemical, arterial blood gas (ABG) analysis, as well as, SDMA, and KIM-1 concentrations. Spot urine samples for routine urinalysis, some biochemical parameters, NAG activity, and THP concentration. Groups II and III showed microcytic hypochromic anemia and significant leukopenia, significant increases in serum concentrations of SDMA, and KIM-1, and activity of urinary NAG; meanwhile, they showed a significant decrease in urinary THP concentration. Group IV after treatment revealed an improvement of all measured parameters except urinary THP concentration. In conclusion, the current study results found out that SDMA, KIM-1, and NAG could serve as efficient biomarkers of early renal injury detection and treatment follow-up. | |
| 520 | 3 | _aتعتبر أمراض الكلى من أكثر المشكلات الطبية شيوعًا في القطط والتي تسبب خلل فسيولوجي وأيضي. العديد من الأسباب الفسيولوجية المرضية قد تتسبب في إحداثها من بينها الإصابة الحادة للكلي بالتلف والذي بدوره يؤدي إلى إنحدار سريع في وظائف الكلى وقد ينتهي بفشل مزمن في وظائف الكلى. يعنبر القط الحيوان الأكثر إصابة ووفاة من أمراض الكلى المزمنة من أي حيوان آخر خاصة القطط الكبيرة في السن بنسبة حدوث 80 %. الدلالات الحيوية هي جزيئات حيوية، غالبًا ما تكون بروتينات، تتأرجح (زيادة أو نقصان) نتيجة التغيرات المرضية. بدأ عصر جديد في مجال طب وأمراض الكلى مع ظهور الدلالات الحيوية الجديدة الخاصة بتلف الكلى، كما أنها طورت أولوية بحثية ترتبط بتحسين التشخيص والمتابعة والتكهن وصنع القرارات والأدوات الجديدة الخاصة بأمراض الكلى. | |
| 530 | _aIssues also as CD. | ||
| 546 | _aText in English and abstract in Arabic & English. | ||
| 650 | 0 | _aCats | |
| 653 | 1 | 
_aSDMA _aurinalysis _aTHP _aNAG _aKIM-1  | 
|
| 700 | 0 | 
_aSafaa Y. S. Ahmed _ethesis advisor.  | 
|
| 700 | 0 | 
_aShaymaa I. Salem _ethesis advisor.  | 
|
| 700 | 0 | 
_aKhaled M. A. Mahran _ethesis advisor.  | 
|
| 700 | 0 | 
_aMohamed E. Ali  _ethesis advisor.  | 
|
| 900 | 
_b01-01-2024 _cSafaa Y. S. Ahmed _cShaymaa I. Salem _cKhaled M. A. Mahran _cMohamed E. Ali _UCairo University _FFaculty of Veterinary Medicine _DDepartment of Clinical Pathology  | 
||
| 905 | 
_aShimaa _eEman Ghareb  | 
||
| 942 | 
_2ddc _cTH _e21 _n0  | 
||
| 999 | _c172712 | ||